Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Melanoma"" wg kryterium: Temat


Tytuł:
H-VISTA Immunohistochemistry Score Is Associated with Advanced Stages in Cutaneous and Ocular Melanoma.
Autorzy:
Tinca AC; Doctoral School of Medicine and Pharmacy, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Szoke AR; Doctoral School of Medicine and Pharmacy, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Lazar BA; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.
Szász EA; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Faculty of Medicine, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Tomuț AN; Faculty of Medicine, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Sabău AH; Doctoral School of Medicine and Pharmacy, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Cocuz IG; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Cotoi TC; Faculty of Pharmacy, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Niculescu R; Doctoral School of Medicine and Pharmacy, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Chiorean DM; Doctoral School of Medicine and Pharmacy, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.
Ungureanu IA; Faculty of Medicine, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Turdean SG; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Faculty of Medicine, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Cotoi OS; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.; Pathophysiology Department, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 14; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 14.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/metabolism
Melanoma*/pathology
Melanoma*/diagnosis
Skin Neoplasms*/metabolism
Skin Neoplasms*/pathology
Skin Neoplasms*/diagnosis
Immunohistochemistry*/methods
Biomarkers, Tumor*/metabolism
Neoplasm Staging*
Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Adult ; B7 Antigens/metabolism ; Prognosis ; Melanoma, Cutaneous Malignant ; Eye Neoplasms/metabolism ; Eye Neoplasms/pathology ; Eye Neoplasms/diagnosis ; Aged, 80 and over
Czasopismo naukowe
Tytuł:
Surgical Research Progress of Sentinel Lymph Node Biopsy in Melanoma.
Autorzy:
Mou H; Department of Burns & Plastic Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
Tan Q; Department of Burns & Plastic Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2023 Dec; Vol. 36 (1), pp. 2225087.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/surgery
Skin Neoplasms*/diagnosis
Skin Neoplasms*/surgery
Skin Neoplasms*/pathology
Humans ; Sentinel Lymph Node Biopsy ; Lymph Node Excision/adverse effects ; Lymph Nodes/pathology ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Detection for melanoma skin cancer through ACCF, BPPF, and CLF techniques with machine learning approach.
Autorzy:
Kavitha P; Department of Artificial Intelligence and Data Science, Panimalar Engineering College, Chennai, India.
Ayyappan G; Department of Information Technology, Prince Shri Venkateshwara Padmavathy Engineering College, Chennai, India.
Jayagopal P; School of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
Mathivanan SK; School of Computing Science and Engineering, Galgotias University, Greater Noida, Uttar Pradesh, 203201, India.
Mallik S; Department of Environmental Health, Harvard T H Chan School of Public Health, Boston, MA, 02115, USA.; Department of Pharmacology and Toxicology, The University of Arizona, Tucson, AZ, 85721, USA.
Al-Rasheed A; Department of Information Systems, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
Alqahtani MS; Radiological Sciences Department, College of Applied Medical Sciences, King Khalid University, 61421, Abha, Saudi Arabia.; BioImaging Unit, Space Research Centre, University of Leicester, Michael Atiyah Building, Leicester, LE1 7RH, UK.
Soufiene BO; PRINCE Laboratory Research, ISITcom, Hammam Sousse, University of Sousse, Sousse, Tunisia. .
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2023 Dec 06; Vol. 24 (1), pp. 458. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Journal Article
MeSH Terms:
Skin Neoplasms*/diagnostic imaging
Melanoma*/diagnostic imaging
Humans ; Algorithms ; Machine Learning ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
[Efficacy of adjuvant programmed cell death 1 (PD-1) monoclonal antibody immunotherapy in Chinese patients with resected stage Ⅱ-Ⅲ melanoma].
Autorzy:
Ren ZG; Department of Orthopedics, Shanghai Electric Power Hospital, Shanghai 200050, China.
Xu Y; Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Hua ZZ; Department of Orthopedics, Shanghai Electric Power Hospital, Shanghai 200050, China.
Mo ZY; Department of Orthopedics, Shanghai Electric Power Hospital, Shanghai 200050, China.
Wang LW; Department of Orthopedics, Shanghai Electric Power Hospital, Shanghai 200050, China.
Shi GB; Department of Orthopedics, Shanghai Electric Power Hospital, Shanghai 200050, China.
Liu WL; Department of Orthopedics, Shanghai Electric Power Hospital, Shanghai 200050, China.
Sun W; Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zheng BQ; Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Wang CM; Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Jin YJ; Department of Orthopedics, Shanghai Electric Power Hospital, Shanghai 200050, China.
Chen Y; Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Nov 23; Vol. 45 (11), pp. 973-980.
Typ publikacji:
Observational Study; English Abstract; Journal Article
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/pathology
Skin Neoplasms*/drug therapy
Skin Neoplasms*/pathology
Humans ; Antibodies, Monoclonal/therapeutic use ; Apoptosis ; China ; Disease-Free Survival ; East Asian People ; Immunotherapy ; Interferon-alpha/therapeutic use ; Lymphatic Metastasis ; Programmed Cell Death 1 Receptor/therapeutic use ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Genetic Concordance in Primary Cutaneous Melanoma and Matched Metastasis: A Systematic Review and Meta-Analysis.
Autorzy:
Kerkour T; Department of Dermatology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Zhou C; Department of Dermatology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Hollestein L; Department of Dermatology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Mooyaart A; Department of Pathology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 14; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Melanoma*/genetics
Melanoma*/pathology
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Humans ; Proto-Oncogene Proteins B-raf/genetics ; Mutation ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Autorzy:
Zhao S; Department of Burns, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Zhu Y; Department of Burns, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Liu H; Department of Burns, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
He X; Department of Burns, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Xie J; Department of Burns, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. .; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Nov 10; Vol. 21 (1), pp. 801. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/genetics
Skin Neoplasms*/drug therapy
Skin Neoplasms*/genetics
Humans ; Pyroptosis/genetics ; Skin ; Biomarkers, Tumor/genetics ; Pore Forming Cytotoxic Proteins ; Phosphate-Binding Proteins/genetics ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management.
Autorzy:
Gosman LM; Doctoral School, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Department of Pathology, Saint Pantelimon Clinical Emergency Hospital, 021659 Bucharest, Romania.
Țăpoi DA; Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Department of Pathology, University Emergency Hospital, 050098 Bucharest, Romania.
Costache M; Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Department of Pathology, University Emergency Hospital, 050098 Bucharest, Romania.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 01; Vol. 24 (21). Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/etiology
Melanoma*/therapy
Skin Neoplasms*/diagnosis
Skin Neoplasms*/etiology
Skin Neoplasms*/therapy
Humans ; Immunohistochemistry ; Ultraviolet Rays ; Biomarkers ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
Autorzy:
Silva-Clavería F; Melanoma Unit, Department of Medical & Surgical Dermatology, University Hospital Virgen Macarena, Seville, Spain.
Álvarez-Muñoz A; Pathology Department, University Hospital Virgen Macarena, Seville, Spain.
Ferrándiz L; Melanoma Unit, Department of Medical & Surgical Dermatology, University Hospital Virgen Macarena, Seville, Spain.
Fernández-Orland A; Melanoma Unit, Department of Medical & Surgical Dermatology, University Hospital Virgen Macarena, Seville, Spain.
Conde-Martin AF; Pathology Department, University Hospital Virgen Macarena, Seville, Spain.
Moreno-Ramírez D; Melanoma Unit, Department of Medical & Surgical Dermatology, University Hospital Virgen Macarena, Seville, Spain.
Ríos-Martín JJ; Pathology Department, University Hospital Virgen Macarena, Seville, Spain.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Oct; Vol. 31 (7), pp. 1398-1402. Date of Electronic Publication: 2023 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/genetics
Melanoma*/metabolism
Skin Neoplasms*/diagnosis
Skin Neoplasms*/genetics
Skin Neoplasms*/metabolism
Nevus, Pigmented*/pathology
Neoplastic Syndromes, Hereditary*
Humans ; Comparative Genomic Hybridization ; In Situ Hybridization, Fluorescence ; Tumor Suppressor Proteins/genetics ; Ubiquitin Thiolesterase/genetics ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma.
Autorzy:
Woo TE; Department of Medicine, Division of Dermatology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Stukalin I; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Ding PQ; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Goutam S; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Sander M; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Ewanchuk B; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Cheung WY; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Heng DYC; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Cheng T; Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Sep 30; Vol. 30 (10), pp. 8936-8947. Date of Electronic Publication: 2023 Sep 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/pathology
Skin Neoplasms*/drug therapy
Skin Neoplasms*/pathology
Male ; Humans ; Aged ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged, 80 and over ; Child, Preschool ; Female ; Ipilimumab/therapeutic use ; Nivolumab/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Comprehensive analysis of necroptotic patterns and associated immune landscapes in individualized treatment of skin cutaneous melanoma.
Autorzy:
Yang B; Department of Ophthalmology, Chengdu Aier Eye Hospital, Chengdu, Sichuan, China.
Xie P; Department of Plastic and Burns Surgery, National Key Clinical Construction Specialty, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Huai H; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China.
Li J; Department of Plastic and Burns Surgery, National Key Clinical Construction Specialty, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 30; Vol. 13 (1), pp. 21094. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/genetics
Melanoma*/therapy
Skin Neoplasms*/genetics
Skin Neoplasms*/therapy
Humans ; Traction ; Genomics ; Tumor Microenvironment/genetics ; Prognosis ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Impact of COVID-19 pandemic on health equality in malignant melanoma diagnosis.
Autorzy:
Lun LK; Royal Victoria Infirmary, Newcastle, UK.
Cheng H; Royal Victoria Infirmary, Newcastle, UK.
Hussain R; Royal Victoria Infirmary, Newcastle, UK.
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2023 Nov; Vol. 23 (Suppl 6), pp. 62.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/epidemiology
COVID-19*
Skin Neoplasms*/diagnosis
Skin Neoplasms*/epidemiology
Humans ; Pandemics ; Melanoma, Cutaneous Malignant ; COVID-19 Testing
Czasopismo naukowe
Tytuł:
Comparing P53 expression and genome-wide transcriptome profiling to Comet assay in lymphocytes from melanoma patients and healthy controls.
Autorzy:
Najafzadeh M; School of Life Sciences, University of Bradford, Richmond Road, Bradford, BD7 1DP, West Yorkshire, UK. .
Naeem P; School of Life Sciences, University of Bradford, Richmond Road, Bradford, BD7 1DP, West Yorkshire, UK.
Ghaderi N; Bradford Teaching Hospitals NHS Foundation Trust, St Luke's Hospital, Little Horton Lane, BD5 0NA, UK.
Jafarinejad S; School of Life Sciences, University of Bradford, Richmond Road, Bradford, BD7 1DP, West Yorkshire, UK.
Karimi Z; School of Life Sciences, University of Bradford, Richmond Road, Bradford, BD7 1DP, West Yorkshire, UK.
Ghaderi M; Division of Pathology F46, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden.
Akhbari P; Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, EX2 5DW, UK.
Ghaderi R; Department of Medicine, Imperial College London, London, SW7 2BX, UK.
Farsi P; Department of Clinical Pathology and Cytology, Karolinska University Hospital, 141 86, Stockholm, Sweden.
Wright A; Bradford Teaching Hospitals NHS Foundation Trust, St Luke's Hospital, Little Horton Lane, BD5 0NA, UK.
Anderson D; School of Life Sciences, University of Bradford, Richmond Road, Bradford, BD7 1DP, West Yorkshire, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 01; Vol. 13 (1), pp. 18858. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Tumor Suppressor Protein p53*/genetics
Melanoma*/genetics
Melanoma*/pathology
Humans ; Comet Assay ; Lymphocytes/pathology ; DNA Damage ; Ultraviolet Rays/adverse effects ; Gene Expression Profiling ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Multi-cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma.
Autorzy:
Yan J; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, China.
Deng L; Western Medical Branch of the Chinese PLA General Hospital, Beijing, China.
Yu J; Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
Wu X; Department of Renal Cancer and Melanoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
Wang S; Henan Key Laboratory of Imaging and Intelligent Processing, PLA Strategic Support Force Information Engineering University, Zhengzhou, China.
Cang S; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Nov; Vol. 13 (11), pp. e1478.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/genetics
Skin Neoplasms*/drug therapy
Skin Neoplasms*/genetics
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Biomarkers ; Cohort Studies ; Mutation/genetics ; Melanoma, Cutaneous Malignant
Raport
Tytuł:
Tumor cell-induced platelet aggregation accelerates hematogenous metastasis of malignant melanoma by triggering macrophage recruitment.
Autorzy:
Chen Y; Department of Oncology, Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing, China.
Zhou J; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Liu Z; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Wu T; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Li S; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Zhang Y; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Yin X; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Yang G; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China. guowang_.
Zhang G; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Oct 23; Vol. 42 (1), pp. 277. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*
Lung Neoplasms*
Humans ; Platelet Aggregation/physiology ; Macrophages ; Tumor Microenvironment ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Autorzy:
Maekawa N; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.; Cancer Research Unit, One Health Research Center, Hokkaido University, Sapporo, Japan.
Konnai S; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.; Cancer Research Unit, One Health Research Center, Hokkaido University, Sapporo, Japan.; Faculty of Veterinary Medicine, Department of Disease Control, Hokkaido University, Sapporo, Japan.; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.
Hosoya K; Cancer Research Unit, One Health Research Center, Hokkaido University, Sapporo, Japan.; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.
Kim S; Cancer Research Unit, One Health Research Center, Hokkaido University, Sapporo, Japan.; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.
Kinoshita R; Cancer Research Unit, One Health Research Center, Hokkaido University, Sapporo, Japan.; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.
Deguchi T; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.; Department of Companion Animal Clinical Sciences, Companion Animal Internal Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Owaki R; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.
Tachibana Y; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.
Yokokawa M; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.
Takeuchi H; Faculty of Veterinary Medicine, Department of Disease Control, Hokkaido University, Sapporo, Japan.
Kagawa Y; North Lab, Sapporo, Japan.
Takagi S; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.; Department of Veterinary Surgery 1, School of Veterinary Medicine, Azabu University, Sagamihara, Japan.
Ohta H; Faculty of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.; Department of Companion Animal Clinical Sciences, Companion Animal Internal Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Kato Y; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yamamoto S; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.; Fuso Pharmaceutical Industries, Ltd., Osaka, Japan.
Yamamoto K; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.; Fuso Pharmaceutical Industries, Ltd., Osaka, Japan.
Suzuki Y; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan.
Okagawa T; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.
Murata S; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.; Faculty of Veterinary Medicine, Department of Disease Control, Hokkaido University, Sapporo, Japan.
Ohashi K; Faculty of Veterinary Medicine, Department of Advanced Pharmaceutics, Hokkaido University, Sapporo, Japan.; Faculty of Veterinary Medicine, Department of Disease Control, Hokkaido University, Sapporo, Japan.; Faculty of Veterinary Medicine, International Affairs Office, Hokkaido University, Sapporo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 04; Vol. 18 (10), pp. e0291727. Date of Electronic Publication: 2023 Oct 04 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/veterinary
Melanoma*/pathology
Mouth Neoplasms*/veterinary
Adenocarcinoma*
Osteosarcoma*/drug therapy
Osteosarcoma*/veterinary
Humans ; Dogs ; Animals ; Hospitals, Animal ; Hospitals, Teaching ; Treatment Outcome ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Standardized Computer-Assisted Analysis of 5-hmC Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas.
Autorzy:
Koch EAT; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.
Berking C; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.
Erber R; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.; Institute of Pathology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Erdmann M; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.
Kiesewetter F; MVZ Pathology, Sozialstiftung Bamberg, 96049 Bamberg, Germany.
Schliep S; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.
Heppt MV; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), 91054 Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 28; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Dysplastic Nevus Syndrome*/genetics
Dysplastic Nevus Syndrome*/pathology
Skin Neoplasms*/pathology
Melanoma*/pathology
Humans ; Computers ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma.
Autorzy:
Schäfer H; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112, Halle (Saale), Germany.
Subbarayan K; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112, Halle (Saale), Germany.
Massa C; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112, Halle (Saale), Germany.
Vaxevanis C; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112, Halle (Saale), Germany.
Mueller A; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112, Halle (Saale), Germany.
Seliger B; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112, Halle (Saale), Germany. .; Fraunhofer Institute for Cell Therapy and Immunology, Perlickstr. 1, 04103, Leipzig, Germany. .; Institute of Translational Medicine, Medical School Brandenburg, Hochstr. 29, 14770, Brandenburg an der Havel, Germany. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Sep 20; Vol. 21 (1), pp. 643. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/genetics
Skin Neoplasms*/genetics
Humans ; Tumor Escape ; Carcinogenesis ; Tumor Microenvironment ; Glycoproteins ; Extracellular Matrix Proteins ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Development and validation of two online dynamic nomograms for patients with non-distant metastatic cutaneous melanoma based on surgical approaches.
Autorzy:
Wang S; Department of Burns and Plastic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.; Department of Burns and Plastic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Chen Y; Diabetic Foot Center, Nanjing Junxie Hospital, Nanjing, People's Republic of China.
Sun J; Department of Burns and Plastic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Mo R; Department of Burns and Plastic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Tan Q; Department of Burns and Plastic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 18479-18490. Date of Electronic Publication: 2023 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/surgery
Skin Neoplasms*/surgery
Neoplasms, Second Primary*
Humans ; Nomograms ; Neoplasm Staging ; Prognosis ; SEER Program ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
Comparative analysis identifies genetic and molecular factors associated with prognostic clusters of PANoptosis in glioma, kidney and melanoma cancer.
Autorzy:
Mall R; Department of Immunology, St. Jude Children's Research Hospital, MS #351, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA.; Biotechnology Research Center, Technology Innovation Institute, P.O. Box 9639, Abu Dhabi, United Arab Emirates.
Kanneganti TD; Department of Immunology, St. Jude Children's Research Hospital, MS #351, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 28; Vol. 13 (1), pp. 20962. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/genetics
Skin Neoplasms*/genetics
Glioma*
Carcinoma, Renal Cell*
Kidney Neoplasms*
Humans ; Hedgehog Proteins ; Prognosis ; Kidney ; Tumor Microenvironment ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma.
Autorzy:
Li X; Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, 410000, People's Republic of China.
Yue Z; Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, 410000, People's Republic of China.
Wang D; Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, 410000, People's Republic of China. .
Zhou L; Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, 410000, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 23; Vol. 13 (1), pp. 20617. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/genetics
Skin Neoplasms*/genetics
Humans ; Tumor Microenvironment ; Phosphoric Monoester Hydrolases ; Biomarkers ; Prognosis ; Leukocyte Common Antigens ; Melanoma, Cutaneous Malignant
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies